Lipocine

CompanyUnited StatesFounded 1997

Lipocine develops 2 assets, the furthest approved (testosterone in hormone deficiency). Mostly small molecule acting on AR and lipid and ceramide metabolism; based in the United States, founded in 1997.

2
Assets
Furthest: Approved; 3
Trials: 2
Signals

Pipeline

testosterone
Oral testosterone replacement therapy acting as an androgen receptor agonist.
Approved, Small molecule, Lipid and ceramide metabolism, AR, hormone deficiency, hypoactive sexual desire disorder
TLANDO
Oral testosterone undecanoate formulation providing testosterone replacement therapy.
Approved, Small molecule, AR, hypogonadism

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

Evidence behind the mechanisms3
Trials3
Signals2
Similar companies6

Updated 8 Oct 2026 · 77 sources